BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 10505111)

  • 1. Potential of gene therapy for the treatment of pituitary tumors.
    Goya RG; Sarkar DK; Brown OA; Hereñú CB
    Curr Gene Ther; 2004 Mar; 4(1):79-87. PubMed ID: 15032616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells.
    Banerjee PS; Ostapchuk P; Hearing P; Carrico I
    J Am Chem Soc; 2010 Oct; 132(39):13615-7. PubMed ID: 20831164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of viral promoters in mammalian cell-based bioassays: How reliable?
    Betrabet SS; Choudhuri J; Gill-Sharma M
    J Transl Med; 2004 Jan; 2(1):1. PubMed ID: 14720299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic cancer vaccination by targeting functional non-self.
    Tuohy VK; Jaini R
    Ann Med; 2011 Aug; 43(5):356-65. PubMed ID: 21651440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prophylactic vaccine for breast cancer? Why not?
    Tuohy VK
    Breast Cancer Res; 2010; 12(6):405. PubMed ID: 21143772
    [No Abstract]   [Full Text] [Related]  

  • 6. An autoimmune-mediated strategy for prophylactic breast cancer vaccination.
    Jaini R; Kesaraju P; Johnson JM; Altuntas CZ; Jane-Wit D; Tuohy VK
    Nat Med; 2010 Jul; 16(7):799-803. PubMed ID: 20512124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.
    Wang HW; Breslin MB; Chen C; Akerstrom V; Zhong Q; Lan MS
    Hum Gene Ther; 2009 Nov; 20(11):1308-18. PubMed ID: 19604042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of metastatic potential.
    Winnard PT; Pathak AP; Dhara S; Cho SY; Raman V; Pomper MG
    J Nucl Med; 2008 Jun; 49 Suppl 2(Suppl 2):96S-112S. PubMed ID: 18523068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptionally targeted gene therapy to detect and treat cancer.
    Wu L; Johnson M; Sato M
    Trends Mol Med; 2003 Oct; 9(10):421-9. PubMed ID: 14557054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters.
    Iyer M; Wu L; Carey M; Wang Y; Smallwood A; Gambhir SS
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14595-600. PubMed ID: 11734653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy.
    Gómez-Navarro J; Arafat W; Xiang J
    Breast Cancer Res; 2000; 2(1):32-44. PubMed ID: 11250691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.
    Anderson LM; Krotz S; Weitzman SA; Thimmapaya B
    Cancer Gene Ther; 2000 Jun; 7(6):845-52. PubMed ID: 10880014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
    Lambright ES; Amin K; Wiewrodt R; Force SD; Lanuti M; Propert KJ; Litzky L; Kaiser LR; Albelda SM
    Gene Ther; 2001 Jun; 8(12):946-53. PubMed ID: 11426335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue specific promoters in targeting systemically delivered gene therapy.
    Hart IR
    Semin Oncol; 1996 Feb; 23(1):154-8. PubMed ID: 8607025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate cancer gene therapy].
    Nasu Y; Kumon H
    Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
    Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
    Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.